KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital: 2009-2023

Historic Return on Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 15 years, with Dec 2023 value amounting to 0.04%.

  • Teva Pharmaceutical Industries' Return on Invested Capital was N/A to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year change of. This contributed to the annual value of 0.04% for FY2023, which is 19.00% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Invested Capital stood at 0.04% for FY2023, which was up 127.89% from -0.15% recorded in FY2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Invested Capital peaked at 0.09% during FY2021, and registered a low of -0.22% during FY2020.
  • In the last 3 years, Teva Pharmaceutical Industries' Return on Invested Capital had a median value of 0.04% in 2023 and averaged -0.01%.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Return on Invested Capital grew by 30bps in 2021, and later fell by 24bps in 2022.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Return on Invested Capital stood at -0.02% in 2019, then decreased by 20bps to -0.22% in 2020, then rose by 30bps to 0.09% in 2021, then declined by 24bps to -0.15% in 2022, then increased by 19bps to 0.04% in 2023.